legal
Missouri Supreme Court ruling could help J&J in talc cases
February 25, 2019Sales and Marketing Cancer, J&J, JJ, asbestos, baby powder, lawsuits, legal, talc
The Missouri Supreme Court has ruled that the practice of combining two or more cases in order to allow courts …
Counterfeit drugs – countering the lies
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent
As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …
Chicago Judge overturns $140 million AbbVie AndroGel verdict
August 13, 2018Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone
A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …
J&J ordered to pay $4.68 billion to talc-powder plaintiffs
July 13, 2018Medical Communications J&J, JJ, Johnson and Johnson, legal, talc powder
A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women …
UK High Court rejects ABPI’s challenge to new NICE cost curbs
October 5, 2017Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical
The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …
Ex-Novartis employee found not guilty of deceitful drug advertising
March 17, 2017Medical Communications, Sales and Marketing Diovan, Novartis, legal
A Tokyo court has ruled finding ex-Novartis employee Nobuo Shirahashi and the company’s Tokyo-based sales arm Novartis Pharma KK not …
AstraZeneca loses legal bid to block Crestor generics
July 20, 2016Research and Development, Sales and Marketing AstraZeneca, Crestor, FDA, generics, legal
A US district court judge has refused AstraZeneca’s request for a temporary restraining order blocking the approval of generic versions …
Pfizer to call off $160 billion merger with Allergan
April 6, 2016Business Services, Research and Development, Sales and Marketing Allergan, Pfizer, deal, legal, merger and acquisition, regulation
US pharma giant Pfizer Inc (NYSE: PFE) has decided to terminate the $160 billion merger with Botox-maker Allergan Plc (NYSE: …
FTC files complaint against Endo for blocking generics of its pain drugs
April 1, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing Endo International, FTC, legal, regulation
The US Federal Trade Commission (FTC) has filed a complaint against Endo International (Nasdaq: ENDP) alleging the company used illegal …
Whistleblower accuses Novartis of paying bribes in Turkey to push sales
April 1, 2016Business Services, Medical Communications, Sales and Marketing Financial, Novartis, legal, reuters
An anonymous whistleblower has accused Swiss drugmaker Novartis (SIX: NOVN) of paying bribes in Turkey through a consulting firm to …
US govt demands records of Novartis’ educational events in kickbacks suit
March 29, 2016Business Services, Manufacturing and Production, Sales and Marketing Novartis, US government, legal, regulation
Swiss pharma major Novartis (VTX: NOVN) has said the US lawsuit has exploded with the regulators demanding information for about …
Legal analysis: compliance top of the agenda for big pharma
September 25, 2015Medical Communications, Sales and Marketing lawyers, legal, pharma industry, reputation
Do you think big pharma suffers from a negative image, and if so, to what extent do you think this …
Round one to Pfizer in Zoloft lawsuit battle
April 20, 2015Sales and Marketing Pfizer, Zoloft, antidepressant, birth defects, law suits, legal, sertraline
Pfizer’s Zoloft did not cause a young boy’s birth defects, a jury has ruled, in the first of a thousand …
Merck in $100 million contraceptive settlement
February 10, 2014Sales and Marketing Merck, birth, birth control, legal, nuvaring
Merck has offered to pay $100 million to resolve thousands of legal claims brought against it for selling a birth …
GSK ruling: Another failing, but will the industry learn?
July 4, 2012Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine
Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …
